In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder-Reference-Cited by-同舟云学术

In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder

Published:2008-08 Issue:1 Volume:42 Page:306-314
ISSN:1053-8119
Container-title:NeuroImage
language:en
Short-container-title:NeuroImage

Author:

Perani Daniela,Garibotto Valentina,Gorini Alessandra,Moresco Rosa Maria,Henin Marta,Panzacchi Andrea,Matarrese Mario,Carpinelli Assunta,Bellodi Laura,Fazio Ferruccio

Publisher

Elsevier BV

Subject

Cognitive Neuroscience,Neurology

Reference60 articles.

1. Diagnostic and statistical manual of mental disorders;American Psychiatric Association,1994

2. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei;Adams;Int. J. Neuropsychopharmacol.,2005

3. Increased ventral striatal monoaminergic innervation in Tourette syndrome;Albin;Neurology,2003

4. Insensitivity to future consequences following damage to human prefrontal cortex;Bechara;Cognition,1994

5. Functional brain imaging of tobacco use and dependence;Brody;J. Psychiatr. Res.,2006

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New horizons for obsessive-compulsive disorder drug discovery: is targeting glutamate receptors the answer?;Expert Opinion on Drug Discovery;2024-08-06

2. Towards zebrafish models to unravel translational insights of obsessive-compulsive disorder: A neurobehavioral perspective;Neuroscience & Biobehavioral Reviews;2024-07

3. Unveiling serotonergic dysfunction of obsessive-compulsive disorder on prefrontal network dynamics: a computational perspective;Cerebral Cortex;2024-06

4. Alterations in adolescent brain serotonin (5HT)1A, 5HT2A, and dopamine (D)2 receptor systems in a nonhuman primate model of early life adversity;Neuropsychopharmacology;2024-04-26

5. 5-HT 2A and 5-HT 2C receptor antagonism differentially modulate reinforcement learning and cognitive flexibility: behavioural and computational evidence;Psychopharmacology;2024-04-10